A Public Citizen report argues that a craze for retatrutide, an unapproved Eli Lilly weight-loss drug that targets three glucose-regulating receptors, has overwhelmed FDA safeguards, with more than 100 companies openly selling it, influencers like Braden Peters, known as "Clavicular," touting it to millions of followers, and at least 14 reported hospitalizations. The group says that under HHS Secretary Robert F. Kennedy Jr., who has called himself a big fan of peptides and pledged to ease regulations on them, the FDA's 14 warning letters have gone largely unenforced, and it recommends the agency move to tougher sanctions.